| Q45774420 | A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth |
| Q53131394 | Antagonistic effect of C19 on migration of vascular smooth muscle cells and intimal hyperplasia induced by chemokine-like factor 1. |
| Q42635450 | C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis. |
| Q36562284 | CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation |
| Q35542124 | Chemokine-like factor 1-derived C-terminal peptides induce the proliferation of dermal microvascular endothelial cells in psoriasis |
| Q90491056 | Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases |
| Q33909030 | Chemokines and angiogenesis in rheumatoid arthritis. |
| Q34051768 | Chemokines and chemokine receptors in arthritis |
| Q36551840 | Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. |
| Q87215118 | Distinct expression of chemokine-like factor 1 in synovium of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis |
| Q36725211 | ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation |
| Q33841318 | Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats |
| Q42537189 | Preparation and characterization of monoclonal antibodies against VSTM1. |
| Q39788565 | Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer. |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q36030309 | The Secreted Form of Transmembrane Protein 98 Promotes the Differentiation of T Helper 1 Cells |